Personalized Risk Estimation Tool for Crohn's Disease
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Personalized Risk Estimation for Crohn's Disease (PRE-CD) tool treatment?
Research shows that identifying patients at risk for complications in Crohn's disease can help target early treatments to prevent issues like surgery and hospitalizations. This suggests that tools like PRE-CD, which estimate risk, could be effective in guiding early interventions to improve patient outcomes.12345
How is the PRE-CD tool treatment different from other treatments for Crohn's disease?
What is the purpose of this trial?
The aim of this study is to develop and assess the feasibility and effect of a web-based, personalized risk-estimation for Crohn's disease (PRE-Crohn's) tool on behaviors and biomarkers associated with risk for Crohn's disease in unaffected first-degree relatives of patients with inflammatory bowel disease. We hypothesize that personalized risk disclosure via the PRE-Crohn's educational tool is both feasible and successful in modifying behaviors associated with Crohn's disease risk and normalizing pre-clinical disease biomarkers when compared to standard Crohn's disease education. Broadly, completion of this project will also help elucidate the role of lifestyle and dietary factors in pre-clinical Crohn's disease development in high-risk individuals, and provide novel insight into potential strategies for disease prevention in this population.
Research Team
Emily W. Lopes, MD
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for individuals over 14 years old who have a first-degree relative with inflammatory bowel disease but do not show signs of the disease themselves. They must be able to understand and fill out questionnaires, give informed consent, and follow all study procedures.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the PRE-Crohn's tool or receive standard Crohn's disease education
Follow-up
Participants are monitored for changes in biomarkers and behaviors
Study Completion
Final assessment of enrollment and retention rates
Treatment Details
Interventions
- Personalized Risk Estimation for Crohn's Disease (PRE-CD) tool
- Standard Crohn's Disease Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
American College of Gastroenterology
Collaborator